Nucleophosmin (NPM), a ubiquitously and abundantly expressed protein, occurs in the nucleolus, shuttling between the nucleoplasm and cytoplasm. The NPM gene is mutated in almost 30% of human acute myeloid leukemia cells. NPM interacts with p53 and p19 Arf , directs localization of p19
INTRODUCTION
Nucleophosmin (NPM; also known as numatrin or B23) is an abundantly and ubiquitously expressed member of the nucleoplasmin family. 1 Mostly present in the nucleolus, NPM has an important role in ribosome biogenesis. 2 NPM rapidly shuttles between the nucleoplasm and cytoplasm, acting as a chaperone for both nucleic acids and proteins. 3 Moreover, NPM is necessary for embryonic development 4, 5 and modulates many cellular functions, including cell survival after DNA damage and genomic stability. 6 Remarkably, the NPM gene is mutated in almost 30% of acute myeloid leukemia cells and is overexpressed in solid tumors. [7] [8] [9] [10] NPM interacts with several cellular proteinsin particular, tumor-suppressor p53 11 and Arf (p19 Arf in mice, p14
Arf in humans) gene products [12] [13] [14] -suggesting a crucial role in tumor development. Recently, it has been demonstrated that NPM protects p19
Arf from degradation and directs its localization in the nucleolus. 6 Hepatocyte odd protein shuttling (HOPS; also referred to as Tmub1) is a ubiquitously expressed protein shuttling between the nucleus and cytoplasm. 15, 16 The HOPS-encoding gene has been isolated in the regenerating liver. In the normal liver HOPS is prevalent in the nucleus but, during liver regeneration, it migrates to the cytoplasm. HOPS export from the nucleus is rapid. Thirty minutes after partial hepatectomy, HOPS migrates to the cytoplasm and moves then back to the nucleus in 12-18 h. 15 cAMP, activated over the first minutes of liver regeneration, permits rapid HOPS export from the nuclear to the cytoplasmic compartments. In cAMP-treated mice, HOPS is likewise exported from the nucleus to cytoplasm of hepatocytes at 60 min of treatment. 15 HOPS ability to migrate might be traced to the presence of a nuclear exporting signal, allowing for an interaction with the exportin CRM-1. 15 HOPS has been credited with effects on cell proliferation and centrosome assembly. In vitro, HOPS knockdown determines centrosome hyperamplification leading to multinucleated cells and micronuclei formation. Moreover, HOPS interacts with many proteins in cytosolic and centrosome complexes. 16 HOPS-abundantly expressed in the brain-has also been identified as an important regulator of basal synaptic transmission. 17 In the central nervous system of knockout mice, Tmub1/HOPS deficiency was found to be associated with behavioral changes, including nocturnal hyperactivity. 18 Therefore, NPM and HOPS share peculiar functions, mostly related to centrosome and cell cycle regulation.
RESULTS

HOPS interaction with NPM and p19
Arf in binary or trimeric complexes The molecular and functional characteristics of HOPS and NPM, as well as their common localization during cell cycle, suggest the occurrence of functional interactions. 5, 6, 15, 16, 19, 20 Using the H-35 rat hepatoma cell line, we found co-localization of HOPS and NPM in the nucleoli (Figure 1a ). Immunoprecipitation (IP) by means of HOPS-specific antibody (Ab-HOPS) in conjunction with an anti-NPM monoclonal antibody (mAb-NPM) demonstrated an interaction between the two molecules ( Figure 1b) . Co-IP with mAb-NPM followed by Ab-HOPS confirmed an association of the two proteins (Supplementary Information S1a).
Previous investigations have pointed to an interaction of NPM with p19
Arf when these proteins are either overexpressed or present at physiological levels. [21] [22] [23] [24] Arf were lysed and proteins were immunoprecipitated with Ab-HOPS, to be revealed by rat anti-p19
Arf mAb (mAb-p19 Arf ; Figure 1c ). In parallel, material immunoprecipitated by mAb-p19
Arf was reacted with Ab-HOPS (Supplementary Information S1b). The results provided evidence for an interaction of HOPS with p19
Arf , further raising the possibility that trimeric complexes might occur physiologically. The occurrence of trimeric complex is not ruled out by the detection of binary complexes in IP assays.
To test whether the three proteins can, in fact, associate as a tricomplex, we used H-35 cells transfected with Flag-p19
Arf . Cell lysates were immunoprecipitated with anti-Flag antibody covalently attached to agarose resin and efficiently eluted by Flag peptide competition. Eluted proteins were immunoprecipitated by mAb-NPM, with the detection step involving Ab-HOPS. Western blotting (WB) analysis after sequential IP showed that p19
Arf , NPM and HOPS occur as a trimeric complex (Figure 1d ). Close intertwining of NPM, HOPS and p19
Arf also suggested shared functionality.
As NPM localizes with p19 Arf in the nucleolus, we asked whether NPM and/or p19
Arf affects HOPS localization in the nucleoli of p19
Arf À / À , p53 À / À and double-knockout p53
(dKO) murine primary fibroblasts (MEFs). In wild-type (WT) MEFs, HOPS appeared to be homogeneously distributed within the nucleus and nucleolus (Figure 1e ). Remarkably, HOPS and NPM displayed an obvious nucleolar co-localization in p19 Arf À / À MEFs (Figure 1f) , demonstrating that the presence of p19
Arf is not essential to HOPS nucleolar localization. In dKO MEFs, HOPS accumulated in the nucleolus (Figure 1g ), despite the absence of NPM. In p53 À / À MEFs, HOPS appeared to be diffusely distributed in the nucleus and nucleolus (Figure 1h ).
IP assays were conducted with WT, p19 Arf À / À , dKO and p53 Arf -expressing vector, using anti-HOPS antibody and anti-HA irrelevant antibody as a negative control (control). WCL and resulting immunocomplexes were resolved by immunoblotting as indicated using anti-p19
Arf antibody (as the target protein) and anti-HOPS antibody (as the IP control). Reverse IP data are shown in Supplementary information S1b. (d) The trimeric complex of HOPS, p19
Arf and NPM was studied in H-35 cells transfected with mycFlag-p19
Arf -expressing vector. Lysates were immunoprecipitated with anti-flag antibody bound resin and eluted by Flag peptide competition. One-fourth of Flag peptide eluted was loaded as a control (input) and the remainder material was immunoprecipitated by anti-NPM antibody (NPM) and anti-HA irrelevant antibody as a negative control (control). Samples were resolved by immunoblotting as indicated and probed with anti-HOPS antibody. (e-h) Subcellular localization of endogenous HOPS and NPM in MEFs (e), p19
Arf À / À MEFs (f ) and p53 À / À MEFs (h). Localization of endogenous HOPS and fibrillarin in dKO MEFs (g). Cells were fixed, permeabilized and decorated with anti-HOPS (red in e, f and h; green in g), anti-NPM (green in e, f and h) or anti-fibrillarin (red in g) antibodies. Protein colocalization is shown in the merged image (merge). Blue, DAPI. Bars, 10 mm. (i-l) IP assays of endogenous HOPS/NPM in MEFs (i), p19
Arf-/-MEFs (j) and in p53 À / À MEFs (l) and of endogenous HOPS/p19
Arf in dKO MEFs (k) Naive cell lysates (2 mg) were immunoprecipitated with anti-HOPS antibody (HOPS) or anti-HA irrelevant antibody as the negative control (control). The WCL and resulting immunocomplexes were resolved by immunoblotting as indicated using anti-NPM antibody (i, j and l) or anti-p19
Arf antibody (k; as the target proteins) and anti-HOPS antibody (i-l; as the IP control). Reverse IP data are shown in Supplementary Information S1c-f. All results are representative of three independent experiments. Arf -expressing vectors or both were harvested after 24, 48 and 72 h post transfection. Cells numbers were determined and analyzed to generate a growth curve. Error bars indicate s.e.m. *Po0.05 and **Po0.01. (f) Top, the same cell samples as described in (e) were analyzed by immunoblotting, as indicated, using anti-p19
Arf and anti-p53 antibodies. Anti-tubulin antibody was used as an internal control. Bottom, densitometry was shown for p19
Arf expression levels. (g) Top, lysates from dKO MEFs infected with pBABE-puro retrovirus (control) or with pBABEpuro retrovirus-expressing HOPS and treated with CHX. Cells were harvested at 0, 2, 4, 6, 12 and 24 h after treatment. HOPS infection control is shown in Supplementary information S2i. Bottom, lysates from p53 À / À MEFs infected with pBABE-puro retrovirus (control), with pBABE-puro retrovirus-expressing HOPS (HOPS) or infected with lentivirus-expressing shRNA for HOPS (siHOPS) were treated as described for dKO MEFs. WB analysis was performed as indicated using anti-p19
Arf antibody and anti-tubulin antibody as an internal control. HOPS infection control is shown in Supplementary Information S2i. Silencing control lysates from p53 À / À MEFs are shown in Supplementary information S2j. All results are representative of three independent experiments.
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HOPS and p19
Arf appeared to be associated in the absence of NPM (Figure 1k ). The HOPS and NPM interaction was observed in p53 À / À MEFs ( Figure 1l ). Furthermore, IP assays of HOPS and NPM in p19
Arf À / À MEFs, as well as of HOPS and p19 Arf in dKO MEFs, proved that p19
Arf is not necessary for HOPS to bind NPM, whereas NPM is not essential for HOPS to associate with p19
Arf .
HOPS stabilized by NPM controls p19 Arf fate
As NPM controls p19 Arf stability, we examined whether NPM is also important in determining HOPS half-life. Experiments were performed in dKO and in p53 À / À MEFs. Cells were exposed to cycloheximide (CHX) to inhibit de novo protein synthesis and harvested at 0, 6, 12 and 24 h of treatment. Noticeable decrease in HOPS protein stability was observed in dKO MEFs (Figure 2a Information S2d-e) . Similar experiments were conducted in p19
Arf À / À MEFs. HOPS half-life was similar in p19
Arf À / À and p53 À / À MEFs (Figure 2c ). Thus, NPM is crucial not only for p19
Arf but also for HOPS stability and could have a critical role in the association of p19
Arf and HOPS in a trimeric complex. (Figure 2d ). To assess whether p19
Arf , stabilized via HOPS, is functionally active and arrests cell growth, we performed experiment in COS-1 cells overexpressing HOPS, p19
Arf or both proteins. As expected, HOPS and more so p19
Arf overexpressions led to arrested cell growth (Figure 2e ), in accordance with previous data. 15, 25, 26 Interestingly, we observed a remarkable reduction in cell growth (B40%) relative to p19
Arf alone, when both HOPS and p19
Arf were co-overexpressed (Figure 2e ). WB analysis performed on the same cells showed an intense stabilization of p19
Arf (Figure 2f ) at 48 and 72 h in cells that were co-transfected with HOPS and p19
Arf with respect to transfection with p19
Arf alone (Figure 2f ). The double-transfected cells (HOPSp19
Arf ) displayed remarkable activation of p53 (Figure 2f ). These data clearly indicate that HOPS overexpression leads to functional activation of p19 Arf , which causes activation of p53 with impaired cell growth.
To clarify whether the effect of NPM in controlling p19
Arf stability occurs directly or via HOPS, we conducted studies with dKO and p53 À / À MEFs. Both populations of MEFs were infected with retrovirus-overexpressing HOPS and were treated with CHX. MEFs infected with empty retrovirus were used as a control. As described previously, 4-6 p19 Arf half-life was strongly reduced in dKO MEFs relative to p53 À / À MEFs, with a reduction in protein amount at 6 h of CHX treatment. At 12 h, p19
Arf was almost undetectable in dKO MEFs relative to p53 À / À MEFs (Figure 2g) . Surprisingly, p19
Arf stability in dKO MEFs infected with HOPS appeared to be similar to that observed in p53 À / À MEFs (Figure 2g ). p19
Arf was present at all time points being examined and was not reduced at 12 h of treatment.
To investigate whether HOPS exerts a direct control over p19
Arf stability, we knocked-down HOPS in p53 À / À MEFs. Stably silenced HOPS (siHOPS) MEFs were treated with CHX. Interestingly, p19
Arf protein amount was reduced in p53 À / À (siHOPS) MEFs with respect to control cells at 6, 12 and 24 h after treatment (Figure 2g ). These data indicated that a low HOPS expression results in p19
Arf destabilization despite the presence of NPM. Overall, these data suggested that the control over p19
Arf stability by NPM involves effects on HOPS stability, which, in turn, controls p19
Arf half-life.
HOPS determines p19
Arf localization in cell
The finding that HOPS is localized in the nucleolus (even in the absence of NPM or p19 Arf ) did not rule out the possibility that HOPS might control not only stability but also localization of p19
Arf . To further substantiate this hypothesis, we examined p19
Arf accumulation and localization in pMT-Arf cells. We knocked-down HOPS in pMT-Arf cells. We performed analyses in stably siHOPS cells (siHOPS pMT-Arf), null cells infected with a scramble sequence (null pMT-Arf) and uninfected pMT-Arf cells used as control. pMT-Arf, null pMT-Arf and siHOPS pMT-Arf cells were exposed to Zn þ þ to induce p19 Arf expression. Kinetic analysis of p19
Arf showed marked expression in both control and null cells (Figure 3a) . In siHOPS cells, we observed reduced accumulation of p19
Arf at 2-48 h of Zn þ þ treatment (Figure 3a) . To investigate whether destabilization could be traced to HOPS downregulation, we transiently transfected siHOPS pMT-Arf cells with HOPS before Zn þ þ treatment. WB analysis showed upregulation of p19
Arf expression up to 48 h, supporting the hypothesis that HOPS depletion affects p19 Arf protein stability (Figure 3a ). The finding of p19
Arf destabilization in HOPS-silenced cells prompted us to investigate whether p19
Arf stability is related to nucleolus localization under HOPS control. We examined p19 GST-HOPS (d, e) . GST protein was used as a negative control. The results were analyzed by using anti-HOPS, as indicated (b, c),
Arf (e) antibodies. Pull-down efficiency was confirmed by immunoblotting, as indicated, using anti-NPM (b), anti-p19 Arf (c) or anti-HOPS (d, e) antibodies. (f, g) WB analysis of GST pull-down assay on in vitro translated NPM (f ) or p19
Arf (g) proteins with equivalent amounts of GST-p19 Arf (f ) or GST-NPM (g) protein performed by adding HOPS purified protein or not, using anti-NPM (f) or anti-p19
Arf (g) antibodies. GST protein was used as a negative control. Pull-down efficiency was confirmed by immunoblotting, as indicated, using anti-p19
Arf (f ) anti-NPM (g) antibodies. HOPS amount were quantified using anti-HOPS (f, g). All the results are representative of three independent experiments.
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Arf network M Castelli et al nuclear-diffuse fluorescence in siHOPS pMT-Arf cells with respect to pMT-Arf controls and null pMT-Arf cells (Figure 3b ) where p19 Arf appeared to reside in the nucleolus. Despite the notion that NPM controls nucleolar p19
Arf localization, NPM was similarly localized and expressed in siHOPS and control cells (Figure 3b ). These results suggested that HOPS affects p19
Arf stability and localization even in the presence of NPM.
To better characterize the interaction between HOPS, NPM and p19
Arf , we performed an IP assay of NPM and p19 Arf in siHOPS cells, using different HOPS-silencing constructs, siHOPS-174 and siHOPS-403. Lysates of siHOPS p53 À / À MEFs were immunoprecipitated with anti-p19
Arf antibody and detected using anti-NPM antibody. p53
À / À MEFs and null p53 À / À MEFs were used as a control. The results showed association between NPM and p19 Arf in both types of control MEFs, with a minor interaction in siHOPS MEFs, as displayed by densitometric analysis (Figure 4a ). These results demonstrated that HOPS is important for NPM to bind p19
Arf . Similar results were obtained in a reverse IP assay (Supplementary Information S3) . In vitro-binding assays with purified HOPS, p19
Arf and NPM were performed to assess any direct interactions among the three proteins. HOPS protein interacted with NPM and with p19
Arf (Figures 4b-e) . Interestingly, the NPM-p19
Arf interaction was strongly enhanced by the presence of HOPS (Figures 4f and g ). Overall, these results demonstrate that HOPS can specifically act as a bridge, enhancing binding between NPM and p19 Arf . In several hematological malignancies, the NPM locus is lost or translocated. 7 Recently, NPM mutated forms have been identified in about one-third of adult patients with acute myeloid leukemia. 7, 9, [27] [28] [29] [30] The most typical feature of NPM mutants is their aberrant localization in the cytoplasm of leukemic cells. Moreover, NPM mutants recruit the WT form of NPM and p19
Arf to the cytoplasm. 6, 9, 31 To clarify the link between HOPS and p19 Arf and their relationship to NPM, we analyzed HOPS and p19
Arf localization in dKO and siHOPS dKO MEFs transfected with the NPM mutated form (NPMmut) with cytoplasmic localization. IP assays were performed with HOPS and NPMmut, demonstrating a link between the two proteins ( Figure 5a ). dKO cells transfected with NPM and NPMmut showed HOPS nuclear localization with NPM and its translocation into the cytoplasm in the presence of NPMmut (Figure 5b ). As expected, in dKO MEFs transfected with NPMmut, the presence of NPM was restricted to the cytoplasm, and p19 Arf appeared to co-translocate (Figure 5c ). Similar experiments were performed with siHOPS dKO MEFs (Figure 5c ). Although NPMmut and p19
Arf translocated into the cytoplasm of control and null infected cells, p19 Arf appeared to be diffusely distributed in the nucleus of siHOPS dKO MEFs and did not associate with NPMmut in the cytoplasm (Figure 5c ).
To evaluate the influence of HOPS on p19 Arf localization in the presence of NPMmut, we compared the number of cells where p19
Arf was present in the cytoplasmic or nuclear compartments in control, null or siHOPS cells (Figure 5d ). The data clearly indicated that, in siHOPS cells, there occurred an enrichment of p19
Arf in the nucleus (Figure 5e ).
DISCUSSION
NPM is an important regulator of several cell functions, including DNA repair, differentiation and survival. 1 Furthermore, NPM has a pivotal role in cell proliferation, by controlling p19
Arf stabilization and localization. In turn, p19
Arf is a powerful tumor suppressor that regulates cell proliferation by the p53-independent and p53-dependent pathways. p19
Arf levels are critical in the cell's control of Mdm2/p53 balance. 32, 33 NPM establishes a complex axis with p19
Arf that has not been fully elucidated yet. Here, we describe a novel role for HOPS as a bridging protein in the NPM-p19
Arf interaction. We found that HOPS is not a passive bystander and it has, instead, an active role in the NPM-p19 Arf axis, in the form of either dimeric (HOPS-p19
Arf and HOPS-NPM) or trimeric complexes.
Our findings indicate that HOPS acts as a regulator of the association between NPM and p19 Arf . The data also indicate that HOPS is involved in the control of p19
Arf stabilization and localization, and that it mediates the NPM-p19
Arf interaction. Stabilization and nucleolar localization are crucial for p19
Arf to exert its function. Previous investigations have demonstrated that NPM has a pivotal role in the control of p19
Arf . Loss of NPM in the cell reduces p19
Arf half-life, with alterations in function and loss of nucleolar localization. [4] [5] [6] As NPM is critical in controlling HOPS half-life, which, in turn, has a direct effect on p19
Arf stability, our current results further demonstrate that NPM has a control over p19
Arf by HOPS. We found that HOPS overexpression, by increasing p19
Arf half-life, regulates cell growth and modulates p53. Furthermore, p19
Arf localization was influenced by the levels of HOPS, as demonstrated by the use of siHOPS pMT-Arf cells. This function of HOPS, involving p19
Arf stability, could have a central role in the ARF/ Mdm2/p53 pathway, which is critical in a number of cell functions, including transformation, apoptosis and senescence. 34, 35 In vitro experiments performed with recombinant proteins and the mutated form of NPM-that acquires cytoplasmic localization and translocates p19
Arf to the cytoplasm only in the presence of HOPS-clearly established HOPS as a crucial element in the binding of NPM to p19
Simultaneous translocation of HOPS and p19
Arf to the cytoplasm using the NPM mutated form appears to be of great interest. Mutated NPM is, indeed, present in about one-third of adult patients affected by acute myeloid leukemia, a condition in which the molecular pathogenesis has been mechanistically unclear.
Critical questions still remain unanswered. Further studies should clarify where and when NPM, HOPS and p19
Arf interact with one another either as a trimeric complex or as a binary complex. As p19
Arf is a tumor suppressor gene, [24] [25] [26] 36 the question arises of whether the HOPS, NPM and p19
Arf complex is involved in the control of cell proliferation. Although a role for NPM and p19
Arf has clearly been demonstrated, their overall function may need reevaluation in the light of HOPS involvement, as revealed by stabilization of p19
Arf in cells overexpressing HOPS (Figure 6 ). At present, it is unclear whether the presence of HOPS in the cytoplasm of proliferating cell affects p19
Arf susceptibility to degradation, which, in turn, affects the cell's ability to proliferate. Nor can we exclude that additional and more complex mechanisms involving NPM, HOPS and p19
Arf contribute to controlling cell proliferation. Nevertheless, our current data are the first to suggest a crucial role for HOPS within the NPM-p19
Arf interaction.
MATERIALS AND METHODS
Cell culture, transfection and infection
Arf À / À and p53 À / À NPM À / À MEFs, Phoenix and HEK-293T packaging cell lines were cultured at 37 1C as described previously. 4, 15, 16 For transfection experiments, we used a pEGFP vector expressing GFP protein or a pcDNA3 vector expressing the NPM protein or a pcDNA3 vector expressing mycFlag-p19
Arf fusion protein or a pSGV vector expressing HOPS or PINCO vector expressing the GFP-NPMmut fusion protein. For infection experiments, we used a pBABE retroviral vector, carrying puromycin resistance, expressing HOPS protein. Empty or recombinant DNAs were transfected into Phoenix packaging cell lines, using the standard calcium phosphate precipitate method, and after 48 h, supernatants were used to infect target cells. Transient transfections were performed using Lipofectamine 2000 (Invitrogen, Frederick, MD, USA) according to manufacturer's instructions. MEFs were treated with 100 mM CHX (SigmaAldrich, St Louis, MO, USA) in complete medium without antibiotics to block protein synthesis and were lysed at increasing times for immunoblot analyses. pMT-Arf cells were treated with 80 mM ZnSO 4 (Sigma-Aldrich) in a HOPS in the nucleophosmin-p19
Arf network M Castelli et al complete medium without antibiotics to induce p19
Arf protein expression and evaluated by immunoblotting and immunofluorescence assays at different hours from exposure.
RNA interference
To generate stable knockdown cell lines the following Mission short interfering RNA (shRNA) plasmids were purchased from Sigma-Aldrich: 
HOPS
Antibodies
The primary antibodies used were as follows: rabbit polyclonal against whole HOPS, 15 mouse monoclonal anti-NPM1, 37 mouse monoclonal antimyc (Sigma-Aldrich), mouse monoclonal anti-p53 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), mouse monoclonal antifibrillarin (Abcam, Cambridge, UK), rat monoclonal anti-p19
Arf (Merck KGaA, Calbiochem, Darmstadt, Germany), mouse monoclonal anti-GFP (Roche, Basel, Switzerland), mouse monoclonal anti-Flag (Sigma-Aldrich) and mouse monoclonal anti-HA (Sigma-Aldrich). Mouse monoclonal anti-btubulin antibody (Sigma-Aldrich) was used as a control.
IP WB and immunofluorescence analyses IP, WB and immunofluorescence experiments were performed as described previously. 16 For IP, H-35 and different MEFs cells were lysed in radioimmuno precipitation assay (RIPA) buffer with Protease Inhibitor Cocktail (Sigma-Aldrich). Protein concentrations in cell lysates were determined by Bio-Rad assay protein (Bio-Rad Laboratories, Hercules, CA, USA) and appropriate amounts of these samples were immunoprecipitated. Antibodies were added overnight, and protein A or G beads were added for an additional 2 h. We dissolved the proteins precipitated in sodium dodecyl sulfate Laemmli buffer to be fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
For WB, cell lysated with hot Laemmli or IP complexes were fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins were transferred onto a nitrocellulose membrane, which was then incubated with specific primary antibody in 5% fat-free milk, followed by incubation with horse radish peroxidase-conjugated anti-mouse or antirabbit antibodies. All hybridizations were detected by chemiluminescence ECL (GE Healthcare, Amersham Bioscience, Piscataway, NJ, USA).
Treated or untreated H-35, pMT-Arf cells and MEFs grown on cover slips, were fixed and incubated in blocking buffer containing 4% paraformaldehyde. Fixed cover slips were washed three times in phosphate-buffered saline, permeabilized in 0.2% Triton X-100 and incubated in blocking buffer (phosphate-buffered saline plus 3% bovine serum albumin). Cells were incubated in blocking buffer containing the specific primary antibodies: polyclonal anti-HOPS, monoclonal anti-NPM1, anti-GFP and anti-fibrillarin and monoclonal anti-p19 Arf , monoclonal anti-Flag, monoclonal anti-HA, monoclonal anti-b-tubulin antibodies. Antibody binding was revealed by incubation with specific secondary antibodies: Alexa Fluor488 fluorescein isothiocyanate-conjugated anti-mouse immunoglobulin G and Alexa Fluor555 Texas-Red-conjugated anti-rabbit and anti rat immunoglobulin G (Invitrogen, Molecular Probes, Eugene, OR, USA). Nuclei were stained with 4,6-diamidino-2-phenylindole (Sigma-Aldrich). We mounted stained cells on glass slides to be examined by Zeiss Axioplan fluorescence microscope controlled by Spot-2 cooled camera (Diagnostic Instruments, Sterling Heights, MI, USA).
Sequential IP to isolate trimeric complex H-35 cells were transfected with myc-Flag-p19 Arf , then the whole lysates were first immunoprecipitated using an affinity resin with anti-Flag M2 (Sigma-Aldrich). The complex was eluted with Flag peptide (Sigma-Aldrich) and the resulting material was further immunoprecipitated using anti-NPM1. The immunocomplex was subjected to immunoblotting using anti-HOPS. Arf is retained in the nucleus despite the cytosolic export of the NPM mutated form. 
Real-time quantitative PCR
Total RNA (3 mg) extracted from untreated and CHX-treated p53 À / À and dKO MEFs were reversed transcribed using RevertAid H Minus M-MuLV RT (Thermo Fisher Scientific Inc., Fermentas, Waltham, MA, USA) and random hexamer primers. Real-Time PCR amplifications were performed using Mx3000P Real-Time PCR System using Brilliant SYBR Green QPCR Master Mix (Agilent Technologies, Inc., Stratagene, Santa Clara, CA, USA) and ROX as the reference dye. HOPS-specific primers were as follows: forward, In vitro transcription, translation and GST pull-down assay
In vitro transcription/translation assays were performed essentially as described previously. 38 Briefly, the coupled in vitro transcription and translation reactions were performed using the TNT kit as per manufacturer's instructions (Promega Corporation, Madison, WI, USA). For GST pull-down assay, GST fusion proteins bound to glutathioneSepharose 4B beads (GE Healthcare, Amersham Biosciences) were incubated and rotated overnight at 4 1C with in vitro translated proteins in binding buffer (0.1% Nonidet P-40, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, Sigma-Aldrich). Following extensive washing in binding buffer, beads were boiled and the supernatant was analyzed by immunoblotting.
All experiments were performed in triplicate.
